ORIC Pharmaceuticals Inc (ORIC)
9.69
+0.21
(+2.22%)
USD |
NASDAQ |
Nov 05, 16:00
9.69
0.00 (0.00%)
After-Hours: 18:14
ORIC Pharmaceuticals Enterprise Value: 382.34M for Nov. 4, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 04, 2024 | 382.34M |
| November 01, 2024 | 377.40M |
| October 31, 2024 | 375.28M |
| October 30, 2024 | 378.10M |
| October 29, 2024 | 348.48M |
| October 28, 2024 | 309.68M |
| October 25, 2024 | 288.52M |
| October 24, 2024 | 308.97M |
| October 23, 2024 | 335.78M |
| October 22, 2024 | 328.02M |
| October 21, 2024 | 356.94M |
| October 18, 2024 | 380.22M |
| October 17, 2024 | 359.06M |
| October 16, 2024 | 394.33M |
| October 15, 2024 | 385.16M |
| October 14, 2024 | 386.57M |
| October 11, 2024 | 371.76M |
| October 10, 2024 | 368.23M |
| October 09, 2024 | 367.52M |
| October 08, 2024 | 383.04M |
| October 07, 2024 | 383.75M |
| October 04, 2024 | 391.51M |
| October 03, 2024 | 386.57M |
| October 02, 2024 | 404.21M |
| October 01, 2024 | 421.84M |
| Date | Value |
|---|---|
| September 30, 2024 | 436.65M |
| September 27, 2024 | 464.87M |
| September 26, 2024 | 444.41M |
| September 25, 2024 | 419.02M |
| September 24, 2024 | 471.93M |
| September 23, 2024 | 470.52M |
| September 20, 2024 | 507.20M |
| September 19, 2024 | 500.85M |
| September 18, 2024 | 466.28M |
| September 17, 2024 | 426.07M |
| September 16, 2024 | 418.31M |
| September 13, 2024 | 411.26M |
| September 12, 2024 | 352.71M |
| September 11, 2024 | 411.96M |
| September 10, 2024 | 416.20M |
| September 09, 2024 | 404.21M |
| September 06, 2024 | 394.33M |
| September 05, 2024 | 382.34M |
| September 04, 2024 | 390.10M |
| September 03, 2024 | 423.96M |
| August 30, 2024 | 445.12M |
| August 29, 2024 | 433.13M |
| August 28, 2024 | 431.01M |
| August 27, 2024 | 418.31M |
| August 26, 2024 | 431.72M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-128.03M
Minimum
May 09 2022
1.230B
Maximum
Dec 24 2020
328.86M
Average
298.49M
Median
Oct 19 2021
Enterprise Value Benchmarks
| NovaBay Pharmaceuticals Inc | 3.645M |
| Palatin Technologies Inc | 13.74M |
| iBio Inc | 9.837M |
| Theriva Biologics Inc | -12.61M |
| Oragenics Inc | 1.996M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -31.96M |
| Total Expenses (Quarterly) | 36.02M |
| EPS Diluted (Quarterly) | -0.45 |
| Earnings Yield | -18.16% |